Real-world impact of integrating HIV assisted partner services into 31 facilities in Kenya: a single-arm, hybrid type 2 implementation-effectiveness study

被引:14
|
作者
Sharma, Monisha [1 ]
Naughton, Brienna [1 ,8 ]
Lagat, Harison [4 ]
Otieno, George [4 ]
Katz, David A. [1 ]
Wamuti, Beatrice M. [5 ]
Masyuko, Sarah [1 ,6 ]
Bosire, Rose [7 ]
Mugambi, Mary [6 ]
Paladhi, Unmesha Roy [1 ,2 ]
Weiner, Bryan J. [1 ]
Kariithi, Edward [4 ]
Farquhar, Carey [1 ,2 ,3 ]
机构
[1] Univ Washington, Dept Global Hlth, Seattle, WA USA
[2] Univ Washington, Dept Epidemiol, Seattle, WA USA
[3] Univ Washington, Dept Med, Seattle, WA USA
[4] PATH Kenya, Kisumu, Kenya
[5] Harvard TH Chan Sch Publ Hlth, Boston, MA USA
[6] Kenya Minist Hlth, Nairobi, Kenya
[7] Kenya Govt Med Res Ctr, Nairobi, Kenya
[8] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA
来源
LANCET GLOBAL HEALTH | 2023年 / 11卷 / 05期
基金
美国国家卫生研究院;
关键词
SUB-SAHARAN AFRICA; NOTIFICATION; ACCEPTABILITY; COST; MEN;
D O I
10.1016/S2214-109X(23)00153-5
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Assisted partner services (APS), or exposure notification and HIV testing for sexual partners of individuals diagnosed with HIV (index clients), have been shown to be safe and effective in clinical trials. We assessed the real-world effectiveness of APS when integrated into HIV clinics in western Kenya. Methods In this single-arm, hybrid type 2 implementation science study, we facilitated APS implementation in 31 health facilities in Kenya by training existing health-care staff. We focused on male partner outcomes to assess the impact of APS in reaching male individuals in sub-Saharan Africa, who have lower rates of HIV testing than female individuals. Female individuals (aged >= 18 years or emancipated minor) who tested positive for HIV at participating facilities in Kenya were offered APS; consenting female participants provided contact information for all male sexual partners in the past 3 years. Male partners were notified of their potential HIV exposure and offered a choice of community-based or facility-based HIV testing services (HTS). Female index clients and male partners with HIV were followed up at 6 weeks, 6 months, and 12 months after enrolment, to assess linkage to antiretroviral treatment. Viral load was assessed at 12 months. Findings Between May 1, 2018, and March 31, 2020, 32 722 female individuals received HTS; 1910 (6%) tested positive for HIV, of whom 1724 (90%) received APS. Female index clients named 5137 male partners (median 3 per index [IQR 2-4]), of whom 4422 (86%) were reached with exposure notification and HTS. 524 (12%) of the male partners tested were newly diagnosed with HIV and 1292 (29%) reported a previous HIV diagnosis. At 12 months follow-up, 1512 (88%) female index clients and 1621 (89%) male partners with HIV were taking ART, with few adverse events: 25 (2%) female index clients and seven (<1%) male partners reported intimate partner violence, and 60 (3%) female index clients and ten (< 1%) male partners reported relationship dissolution. Interpretation Evidence from this real-world APS scale-up project shows that APS is a safe, acceptable, and effective strategy to identify males with HIV and retain them in care.
引用
收藏
页码:E749 / E758
页数:10
相关论文
共 23 条
  • [1] Closing the HIV identification gap for men: The impact of assisted partner notification services in a real-world setting in Kenya
    Odhiambo, F.
    Dande, C.
    Onyango, R.
    Nyanaro, G.
    Mulwa, E.
    Aluda, M.
    Agallo, M.
    Miruka, F.
    Aoko, A.
    Bukusi, E. A.
    Cohen, C. R.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 : 125 - 126
  • [2] Real-World Effectiveness and Safety of Hydrogen Inhalation in Chinese Patients with Type 2 Diabetes: A Single-Arm, Retrospective Study
    Ji, Hongxiang
    Zhao, Ziyi
    Liu, Zeyu
    Sun, Ruitao
    Li, Yuquan
    Ding, Xiaoheng
    Ni, Tongshang
    DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 2039 - 2050
  • [3] Quantitative outcomes of a type 2 single arm hybrid effectiveness implementation pilot study for hypertension-HIV integration in Botswana
    Moshomo, Thato
    Gaolathe, Tendani
    Ramotsababa, Mareko
    Molefe-Baikai, Onkabetse Julia
    Mogaetsho, Edwin
    Dintwa, Evelyn
    Gala, Pooja
    Ponatshego, Ponego
    Bogart, Laura M.
    Youssouf, Nabila
    Seipone, Khumo
    Van Pelt, Amelia E.
    Bennett, Kara
    Jaffar, Shabbar
    Ilias, Maliha
    Tonwe, Veronica
    Hurwitz, Kathleen Wirth
    Kebotsamang, Kago
    Steger-May, Karen
    Hirschhorn, Lisa R.
    Mosepele, Mosepele
    IMPLEMENTATION SCIENCE COMMUNICATIONS, 2024, 5 (01):
  • [4] Real-world Effectiveness of Sarilumab in RA: Results from the Open-label, Prospective, Single-arm Observational PROFILE Study
    Kivitz, Alan
    Gottenberg, Jacques Eric
    Bergman, Martin
    Qiu, Chunfu
    van Hoogstraten, Hubert
    de Nijs, Ron
    Bessette, Louis
    RHEUMATOLOGY AND THERAPY, 2024, 11 (06) : 1533 - 1550
  • [5] Effectiveness and Safety of Vortioxetine for Major Depressive Disorder in Real-World Clinical Practice: Results from the Single-Arm RELIEVE China Study
    Wang, Gang
    Xiao, Le
    Ren, Hongye
    Simonsen, Kenneth
    Ma, Jingdong
    Xu, Xiangdong
    Guo, Ping
    Wang, Zhiren
    Bai, Ludong
    Reines, Elin Heldbo
    Hammer-Helmich, Lene
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2022, 18 : 1939 - 1950
  • [6] Evaluating the implementation and impact of a volunteer navigation oncology support programme: study protocol for a pragmatic, real-world hybrid type 2 study
    Rocque, Gabrielle B.
    Dent, D'Ambra N.
    Waugh, Charlotte
    Hill, Emily K.
    Federman, Noah
    Rosenzweig, Ian Bostock
    Morris, Bonny
    Kamal, Arif
    BMJ OPEN, 2025, 15 (01):
  • [7] A Prospective, Multicenter, Single-arm, Observational Study to Evaluate the Safety and Effectiveness of Vedolizumab in Real-world Clinical Practice in China: Interim Analysis of Safety results
    Zheng, C.
    Chen, B.
    Yu, J.
    Wang, X.
    Li, L.
    Hu, Y.
    Xie, L.
    Liu, M.
    Chen, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1437 - I1439
  • [8] Effects of empagliflozin on proinflammatory cytokines and other coronary risk factors in patients with type 2 diabetes mellitus: A single-arm real-world observation
    Singh, Ram B.
    Fatima, Ghizal
    Kumar, Puneet
    Fedacko, Jan
    Mojto, Viliam
    Isaza, Adrian
    SinghVerma, Nar
    Maheshwari, Anuj
    Joshi, Shashank
    Saboo, Banshi
    Saxena, Manoj
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (01) : 17 - 25
  • [9] Safety and Effectiveness of Low-Density Lipoprotein Cholesterol-Lowering Therapy With Evolocumab for Familial Hypercholesterolemia/Hypercholesterolemia in Japan: A Real-World, Postmarketing, Single-Arm Study
    Yokote, Koutaro
    Ako, Junya
    Kitagawa, Kazuo
    Osada, Nobuhiro
    Sheng, Feng
    Sonoda, Masae
    Teramoto, Tamio
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (21):
  • [10] First Interim Analysis of Safety and Effectiveness on Elderly Patients in View Study: A Multicenter, Single-Arm, Prospective, Non-Interventional Study on Vonoprazan in the Real-World Clinical Practice in China
    Xiao, Yinglian
    Xu, Hongwei
    Yang, Li
    Nail, Amy
    Song, Qi
    Xie, Li
    Chen, Minhu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S435 - S436